Natera studies show Signatera test predicts cancer recurrence risk

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/7/2026

1. SPCX
2. CRNX
3. VRTX
4. WMT
5. LMT
6. RXST
7. SPGI
8. RIVN
9. SPY
10. BFH

Go back to Natera studies show Signatera test predicts cancer recurrence risk
(NASDAQ: NTRA) Delayed: 281.60 -2.2 (0.78%)
Previous Close $283.80    52 Week High $13.80 
Open $284.51    52 Week Low $6.52 
Day High $287.64    P/E N/A 
Day Low $278.07    EPS $0.00 
Volume 490,932